Aduro Biotech

YTD

ALL

Why Robinhood?

You can watch Aduro Biotech and buy or sell other stocks, ETFs, and their options commission-free!

About ADRO

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes.

CEO

Stephen T. Isaacs

CEOStephen T. Isaacs

Employees

—

Employees—

Headquarters

Berkeley, California

HeadquartersBerkeley, California

Founded

2008

Founded2008

Employees

—

Employees—

ADRO Key Statistics

Market cap

2.90B

Market cap2.90B

Price-Earnings ratio

-11.49

Price-Earnings ratio-11.49

Dividend yield

—

Dividend yield—

Average volume

1.98M

Average volume1.98M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$40.51

52 Week high$40.51

52 Week low

$18.34

52 Week low$18.34

People also own

Based on the portfolios of people who own ADRO. This list is generated using Robinhood data, and it’s not a recommendation.